Promega Corporation

Caspase-3 Identified as the Key Biomarker for Apoptosis

Promega Homogeneous Bioluminescent Caspase Assays simplify apoptosis detection and are up to 50-100 times more sensitive than competitive caspase technologies. Now, detect caspase-3/7, -8, -9, -2 and -6 activities in multiwell plates using less cells or enzyme and get faster throughput, with same-well multiplexing capability to determine the mechanism of cell death.

Download our Cell Based Assays video.
Closed Format: MP4
Open Format: OGG

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.